BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chiorean RM, Baican A, Mustafa MB, Lischka A, Leucuta DC, Feldrihan V, Hertl M, Sitaru C. Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid Patients. Front Immunol 2018;9:2687. [PMID: 30524436 DOI: 10.3389/fimmu.2018.02687] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Gutjahr A, Heck F, Emtenani S, Hammers AK, Hundt JE, Muck P, Siegel DL, Schmidt E, Stanley JR, Zillikens D, Hammers CM. Bullous pemphigoid autoantibody-mediated complement fixation is abolished by the low-molecular-weight heparin tinzaparin sodium. Br J Dermatol 2019;181:593-4. [PMID: 31124130 DOI: 10.1111/bjd.18156] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
2 Bieber K, Kridin K, Emtenani S, Boch K, Schmidt E, Ludwig RJ. Milestones in Personalized Medicine in Pemphigus and Pemphigoid. Front Immunol 2020;11:591971. [PMID: 33505392 DOI: 10.3389/fimmu.2020.591971] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
3 Zhou T, Peng B, Geng S. Emerging Biomarkers and Therapeutic Strategies for Refractory Bullous Pemphigoid. Front Immunol 2021;12:718073. [PMID: 34504496 DOI: 10.3389/fimmu.2021.718073] [Reference Citation Analysis]
4 Stevens NE, Cowin AJ, Kopecki Z. Skin Barrier and Autoimmunity-Mechanisms and Novel Therapeutic Approaches for Autoimmune Blistering Diseases of the Skin. Front Immunol 2019;10:1089. [PMID: 31156638 DOI: 10.3389/fimmu.2019.01089] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Kridin K, Kowalski EH, Kneiber D, Laufer-Britva R, Amber KT. From bench to bedside: evolving therapeutic targets in autoimmune blistering disease. J Eur Acad Dermatol Venereol 2019;33:2239-52. [PMID: 31314932 DOI: 10.1111/jdv.15816] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
6 Papara C, Zillikens D, Sadik CD, Baican A. MicroRNAs in pemphigus and pemphigoid diseases. Autoimmun Rev 2021;20:102852. [PMID: 33971341 DOI: 10.1016/j.autrev.2021.102852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Göbel M, Eming R. [Management of bullous pemphigoid]. Hautarzt 2019;70:236-42. [PMID: 30874841 DOI: 10.1007/s00105-019-4390-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Boch K, Hammers CM, Goletz S, Kamaguchi M, Ludwig RJ, Schneider SW, Zillikens D, Hadaschik E, Schmidt E. Immunoglobulin M pemphigoid. J Am Acad Dermatol 2021:S0190-9622(21)00106-7. [PMID: 33453342 DOI: 10.1016/j.jaad.2021.01.017] [Reference Citation Analysis]
9 Gornowicz-Porowska J, Kowalczyk MJ, Seraszek-Jaros A, Bowszyc-Dmochowska M, Kaczmarek E, Żaba R, Dmochowski M. A Comparative Analysis of CD32A and CD16A Polymorphisms in Relation to Autoimmune Responses in Pemphigus Diseases and Subepithelial Autoimmune Blistering Disorders. Genes (Basel) 2020;11:E371. [PMID: 32235430 DOI: 10.3390/genes11040371] [Reference Citation Analysis]
10 Ständer S, Holtsche MM, Schmidt E, Hammers CM, Zillikens D, Ludwig RJ, Kridin K. Presence of Cutaneous Complement Deposition Distinguishes between Immunological and Histological Features of Bullous Pemphigoid-Insights from a Retrospective Cohort Study. J Clin Med 2020;9:E3928. [PMID: 33287364 DOI: 10.3390/jcm9123928] [Reference Citation Analysis]
11 Cugno M, Borghi A, Garcovich S, Marzano AV. Coagulation and Skin Autoimmunity. Front Immunol 2019;10:1407. [PMID: 31281319 DOI: 10.3389/fimmu.2019.01407] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
12 Genovese G, Di Zenzo G, Cozzani E, Berti E, Cugno M, Marzano AV. New Insights Into the Pathogenesis of Bullous Pemphigoid: 2019 Update. Front Immunol 2019;10:1506. [PMID: 31312206 DOI: 10.3389/fimmu.2019.01506] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
13 Chen X, Zhao W, Jin H, Li L. Risk Factors for Mucosal Involvement in Bullous Pemphigoid and the Possible Mechanism: A Review. Front Med (Lausanne) 2021;8:680871. [PMID: 34095183 DOI: 10.3389/fmed.2021.680871] [Reference Citation Analysis]
14 Edwards G, Diercks GFH, Seelen MAJ, Horvath B, van Doorn MBA, Damman J. Complement Activation in Autoimmune Bullous Dermatoses: A Comprehensive Review. Front Immunol 2019;10:1477. [PMID: 31293600 DOI: 10.3389/fimmu.2019.01477] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]